JOURNAL OF CELLULAR BIOCHEMISTRY

期刊名
JOURNAL OF CELLULAR BIOCHEMISTRY

J CELL BIOCHEM

ISSN / eISSN
0730-2312 / 1097-4644
目标和范围
The Journal of Cellular Biochemistry publishes descriptions of original research in which complex cellular, pathogenic, clinical, or animal model systems are studied by biochemical, molecular, genetic, epigenetic or quantitative ultrastructural approaches. Submission of papers reporting genomic, proteomic, bioinformatics and systems biology approaches to identify and characterize parameters of biological control in a cellular context are encouraged. The areas covered include, but are not restricted to, conditions, agents, regulatory networks, or differentiation states that influence structure, cell cycle & growth control, structure-function relationships.
研究方向

生化与分子生物学

细胞生物学

CiteScore
11.80 查看趋势图
CiteScore 学科排名
类别 分区 排名
Biochemistry, Genetics and Molecular Biology - Biochemistry Q1 #39/428
Biochemistry, Genetics and Molecular Biology - Molecular Biology Q1 #52/380
Biochemistry, Genetics and Molecular Biology - Cell Biology Q1 #45/274
Web of Science 核心合集
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2023) 分区
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE Q2
CELL BIOLOGY - SCIE Q3
H-index
151
出版国家或地区
UNITED STATES
出版商
Wiley-Liss Inc.
出版周期
Semimonthly
出版年份
1982
年文章数
121
Open Access
NO
通讯方式
WILEY-LISS, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
Posted in September 2021, it took two months for the review process, and feedback was received in November 2021 from a total of three reviewers suggesting major revisions. In mid-November 2021, the revised manuscript (R1) was returned, and after three months, in mid-February 2022, feedback was received from two reviewers. During this time, three reminders were sent, stating that they were still waiting for the response from the final reviewer. It seems that three months is the maximum time for the review process, so the editor made a decision for minor revisions based on the feedback from the two reviewers. One week later, the revised manuscript (R2) was returned, and one month later, in mid-March 2022, a letter from the editor confirming acceptance was received. The editor's processing speed was quite fast, but some reviewers may have been too busy, causing delays in providing feedback and prolonging the submission cycle. Currently, this journal has strict screening criteria for submitted manuscripts: 1) the text should not exceed 25% similarity in plagiarism check, 2) the Figures in the main text are checked for any duplicated images, and 3) the original, uncropped Western blot images with markers should be uploaded. Therefore, the quality of the manuscripts has significantly improved, and it is expected that the journal's impact will gradually increase in the future.
2022-04-12
Excuse me, do you have the email reminding me about the manuscript? I would like to refer to it; it has been 4 months since I sent it for revision. Thank you very much!
2022-10-01

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started